Pricing Log in Create free account

Benitec Biopharma Limited (BNTC) vs Surrozen, Inc. (SRZN)

Benitec Biopharma Limited and Surrozen, Inc. are both Biotechnology companies. Benitec Biopharma Limited and Surrozen, Inc. are of similar size ($295.1M and $294.7M). Benitec Biopharma Limited grew revenue faster over the last twelve months: −1.32% against −8.79%. Benitec Biopharma Limited has the higher net margin (0.00% vs −2,887.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Benitec Biopharma Limited leads on 9 and Surrozen, Inc. on 6.

Valuation

Metric BNTC SRZN Biotechnology median
P/E n/m n/m 8.50
P/S 5,034.47 23.78 9.71
P/B 2.13 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2,636.87 14.92 9.21
Earnings yield (12.08%) (159.31%) (33.15%)
Free cash flow yield (4.40%) (12.78%) (25.50%)

Profitability

Metric BNTC SRZN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (385.28%) 0.00%
Net margin 0.00% (2,887.07%) 0.00%
Free cash flow margin 0.00% (303.92%) 0.00%
Return on equity (33.21%) 387.44% (56.36%)
Return on assets (32.28%) (304.47%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BNTC SRZN Biotechnology median
Revenue growth (TTM) (1.32%) (8.79%) 6.02%
EPS growth (last fiscal year) 6.67% (49.38%) 30.26%
Revenue growth, 5-year CAGR (54.02%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTC SRZN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 34.00 12.14 4.72
Net debt to EBITDA 3.52 2.15 0.96

Dividend

Metric BNTC SRZN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BNTC SRZN Biotechnology median
Market cap 295.08m 294.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack